<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Bras Pneumol</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Bras Pneumol</journal-id>
      <journal-title-group>
        <journal-title>Jornal Brasileiro de Pneumologia : Publica&#xE7;a&#x30B;o Oficial da Sociedade Brasileira de Pneumologia e Tisilogia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1806-3713</issn>
      <issn pub-type="epub">1806-3756</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Pneumologia e Tisiologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24068277</article-id>
      <article-id pub-id-type="pmc">4075861</article-id>
      <article-id pub-id-type="publisher-id">S1806-37132013000400019</article-id>
      <article-id pub-id-type="doi">10.1590/S1806-37132013000400019</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pulmonary histoplasmosis presenting with a halo sign on
CT in an immunocompetent patient</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Pereira</surname>
            <given-names>Graziella Hanna</given-names>
          </name>
          <role>Infectious Disease Specialist</role>
          <aff>Hospital Nipo-Brasileiro de S&#xE3;o Paulo, S&#xE3;o Paulo, Brazil</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Almeida</surname>
            <given-names>Liliane Yuri</given-names>
          </name>
          <role>Pulmonologist</role>
          <aff>Hospital Nipo-Brasileiro de S&#xE3;o Paulo, S&#xE3;o Paulo,
Brazil</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Okubo</surname>
            <given-names>Rosa Shizuda</given-names>
          </name>
          <role>Radiologist</role>
          <aff>Hospital Nipo-Brasileiro de S&#xE3;o Paulo, S&#xE3;o Paulo,
Brazil</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marchiori</surname>
            <given-names>Edson</given-names>
          </name>
          <role>Radiologist</role>
          <aff>Federal University of Rio de Janeiro, Rio de Janeiro,
Brazil</aff>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub-ppub">
        <season>Jun-Aug</season>
        <year>2013</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jun-Aug</season>
        <year>2013</year>
      </pub-date>
      <volume>39</volume>
      <issue>4</issue>
      <fpage>523</fpage>
      <lpage>524</lpage>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License, which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <counts>
        <fig-count count="1"/>
        <ref-count count="6"/>
        <page-count count="2"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>To the Editor:</title>
      <p>Histoplasmosis is a common endemic mycosis. Although most infections in
immunocompetent individuals are self-limiting, some patients develop severe
pneumonitis or other types of chronic pulmonary infection. Specific imaging findings
depend on the organisms involved, the underlying condition of the patient, and his
condition after immune depleting procedures. The disease process in immunocompetent
patients is usually limited to a solitary nodule on chest X-rays or CT scans, but
enlarged hilar or mediastinal lymph nodes can also be observed.(
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
) We report here the case of an immunocompetent patient with
histoplasmosis who presented with a halo sign on CT.</p>
      <p>A 47-year-old man presented with dry cough, chest pain, fatigue, and fever, having
started 15 days prior. He reported neither comorbidities nor a contact with
environments with mold. The patient was negative for HIV by ELISA. Laboratory tests
revealed leukocytosis, elevated C-reactive protein levels (33 mg/L), and
hypertransaminasemia (three-fold higher than the upper limit of normal). CT scanning
revealed a pulmonary nodule with a halo sign in his left lower lobe (<xref ref-type="fig" rid="f01">Figure 1</xref>) and left para-hilar lymph nodes.
Histological examination of a pulmonary biopsy sample obtained during bronchoscopy
showed nonspecific inflammatory alterations. Cultures for mycobacteria and fungi
were negative. Serology by counterimmunoelectrophoresis was positive for
histoplasmosis.</p>
      <p>
<fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><title> A CT scan at the level of the lower lobes showing a nodule
surrounded by ground-glass attenuation (halo sign) in the left lower
lobe.</title></caption><graphic xlink:href="1806-3713-jbpneu-39-04-0523-gf01"/></fig>
</p>
      <p>Treatment was initiated with itraconazole (400 mg/day). After 30 days, a CT scan
showed that the size of the nodule was reduced by half. The patient showed
progressive improvement of clinical symptoms and a reduction of the para-aortic
adenopathy. Treatment was maintained for one year, during which the patient remained
asymptomatic, the nodule completely disappeared, and the lymphadenopathy resolved.
However, histoplasmosis by counterimmunoelectrophoresis remained positive.</p>
      <p>We reported the case of an immunocompetent patient who presented with a halo sign and
lymphadenopathy caused by histoplasmosis, showing a good clinical response after one
year of treatment with itraconazole (400 mg/day). <italic>Histoplasma
capsulatum</italic> is a major endemic human fungal pathogen that can cause a
broad variety of clinical presentations, ranging from mild, focal pulmonary disease
to life-threatening systemic infections.(
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
) In one study, open lung biopsies of 155 patients with undiagnosed lung
lesions showed that infectious etiologies were responsible for 19% of the lesions,
the most common diagnosis in this group being histoplasmosis (41%).(
<xref rid="B02" ref-type="bibr">
<sup>2</sup>
</xref>
)
</p>
      <p>The halo sign is characterized by a ground-glass opacity surrounding a nodule, mass,
or round area of consolidation.(
<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>
) This sign is frequently an early indicator of invasive pulmonary
aspergillosis in immunocompromised patients,(
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
) but it might also indicate other invasive fungal diseases.</p>
      <p>Our patient required treatment with high doses of itraconazole for one year. Azoles,
such as itraconazole and voriconazole, and amphotericin B have significant activity
against <italic>H. capsulatum.</italic> However, approximately 10% of the patients
hospitalized due to histoplasmosis die,(
<xref rid="B05" ref-type="bibr">
<sup>5</sup>
</xref>
) despite the lack of antifungal resistance among recovered
isolates.(
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
)
</p>
      <p>In conclusion, a halo sign on CT might indicate active histoplasmosis, which may
require long-term treatment, even in immunocompetent patients.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="B01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chong</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Yi</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary fungal infection: imaging findings in
immunocompetent and immunocompromised patients</article-title>
          <source> Eur J Radiol</source>
          <year>2006</year>
          <volume>59</volume>
          <issue>3</issue>
          <fpage>371</fpage>
          <lpage>383</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ejrad.2006.04.017PMid:16725293">http://dx.doi.org/10.1016/j.ejrad.2006.04.017
PMid:16725293</ext-link>
          <pub-id pub-id-type="pmid">16725293</pub-id>
        </element-citation>
      </ref>
      <ref id="B02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Georgiadou</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Sampsonas</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Rice</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Granger</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Swisher</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kontoyiannis</surname>
              <given-names>DP</given-names>
            </name>
          </person-group>
          <article-title>Open-lung biopsy in patients with undiagnosed lung
lesions referred at a tertiary cancer center is safe and reveals
noncancerous, noninfectious entities as the most common
diagnoses</article-title>
          <source> Eur J Clin Microbiol Infect Dis</source>
          <year>2013</year>
          <volume>32</volume>
          <issue>1</issue>
          <fpage>101</fpage>
          <lpage>105</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10096-012-1720-9">http://dx.doi.org/10.1007/s10096-012-1720-9</ext-link>
          <pub-id pub-id-type="pmid">22895891</pub-id>
        </element-citation>
      </ref>
      <ref id="B03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>CI</given-names>
            </name>
            <name>
              <surname>Marchiori</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>AS</given-names>
              <suffix>J&#xFA;nior</suffix>
            </name>
            <name>
              <surname>M&#xFC;ller </surname>
              <given-names>NL</given-names>
            </name>
            <collab>Comiss&#xE3;o de Imagem da Sociedade Brasileira de
Pneumologia e Tisiologia</collab>
          </person-group>
          <article-title>Illustrated Brazilian consensus of terms and
fundamental patterns in chest CT scans</article-title>
          <source> J Bras Pneumol</source>
          <year>2010</year>
          <volume>36</volume>
          <issue>1</issue>
          <fpage>99</fpage>
          <lpage>123</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1590/S1806-37132010000100016">http://dx.doi.org/10.1590/S1806-37132010000100016</ext-link>
          <pub-id pub-id-type="pmid">20209314</pub-id>
        </element-citation>
      </ref>
      <ref id="B04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greene</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Schlamm</surname>
              <given-names>HT</given-names>
            </name>
            <name>
              <surname>Oestmann</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Stark</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Durand</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lortholary</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Imaging findings in acute invasive pulmonary
aspergillosis: clinical significance of the halo sign</article-title>
          <source> Clin Infect Dis</source>
          <year>2007</year>
          <volume>44</volume>
          <issue>3</issue>
          <fpage>373</fpage>
          <lpage>379</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1086/509917">http://dx.doi.org/10.1086/509917</ext-link>
          <pub-id pub-id-type="pmid">17205443</pub-id>
        </element-citation>
      </ref>
      <ref id="B05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nosanchuk</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Zancop&#xE9;-Oliveira</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Hamilton</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Guimar&#xE3;es</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Antibody therapy for histoplasmosis</article-title>
          <source> Front Microbiol</source>
          <year>2012</year>
          <volume>3</volume>
          <fpage>21</fpage>
          <lpage>21</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3389/fmicb.2012.00021">http://dx.doi.org/10.3389/fmicb.2012.00021</ext-link>
          <!--<pub-id pub-id-type="pmcid">3270318</pub-id>-->
          <pub-id pub-id-type="pmid">22347215</pub-id>
        </element-citation>
      </ref>
      <ref id="B06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brilhante</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Fechine</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Mesquita</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Cordeiro</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Monteiro</surname>
              <given-names>AJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Histoplasmosis in HIV-positive patients in Cear&#xE1; ,
Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility
of Histoplasma capsulatum isolates</article-title>
          <source> Trans R Soc Trop Med Hyg</source>
          <year>2012</year>
          <volume>106</volume>
          <issue>8</issue>
          <fpage>484</fpage>
          <lpage>488</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.trstmh.2012.05.003">http://dx.doi.org/10.1016/j.trstmh.2012.05.003</ext-link>
          <pub-id pub-id-type="pmid">22703696</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article id="S01" article-type="translation" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Cartas ao Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Histoplasmose pulmonar presente com sinal do halo em TC
em um paciente imunocompetente</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Pereira</surname>
            <given-names>Graziella Hanna</given-names>
          </name>
          <role>Infectologista</role>
          <aff>Hospital Nipo-Brasileiro de S&#xE3;o Paulo, S&#xE3;o Paulo (SP)
Brasil</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Almeida</surname>
            <given-names>Liliane Yuri</given-names>
          </name>
          <role>Pneumologista</role>
          <aff>Hospital Nipo-Brasileiro de S&#xE3;o Paulo, S&#xE3;o Paulo (SP)
Brasil</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Okubo</surname>
            <given-names>Rosa Shizuda</given-names>
          </name>
          <role>Radiologista</role>
          <aff>Hospital Nipo-Brasileiro de S&#xE3;o Paulo, S&#xE3;o Paulo (SP)
Brasil</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marchiori</surname>
            <given-names>Edson</given-names>
          </name>
          <role>Radiologista</role>
          <aff>Universidade Federal do Rio de Janeiro, Rio de Janeiro
(RJ) Brasil</aff>
        </contrib>
      </contrib-group>
    </front-stub>
    <body>
      <sec>
        <title>Ao Editor:</title>
        <p>A histoplasmose &#xE9; uma micose end&#xEA;mica comum. Embora a maioria das infec&#xE7;&#xF5;es em
indiv&#xED;duos imunocompetentes seja autolimitada, alguns pacientes apresentam
pneumonite grave ou outros tipos de infec&#xE7;&#xE3;o pulmonar cr&#xF4;nica. Achados
espec&#xED;ficos em exames de imagem dependem dos organismos envolvidos, da condi&#xE7;&#xE3;o
subjacente do paciente e de sua condi&#xE7;&#xE3;o ap&#xF3;s procedimentos de deple&#xE7;&#xE3;o
imunol&#xF3;gica. O processo da doen&#xE7;a em pacientes imunocompetentes &#xE9; geralmente
limitado a um n&#xF3;dulo solit&#xE1;rio na radiografia ou TC de t&#xF3;rax, mas linfonodos
hilares ou mediastinais aumentados tamb&#xE9;m podem ser observados.(
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
) Relatamos aqui o caso de um paciente imunocompetente com
histoplasmose cuja TC apresentou o sinal do halo. </p>
        <p>Um homem de 47 anos de idade apresentou tosse seca, dor tor&#xE1;cica, fadiga e febre,
com in&#xED;cio 15 dias antes. N&#xE3;o relatou comorbidades ou contato com ambientes com
mofo. O resultado do ELISA foi negativo para HIV. Os exames laboratoriais
revelaram leucocitose, n&#xED;veis elevados de prote&#xED;na C reativa (33 mg/L) e
hipertransaminasemia (tr&#xEA;s vezes maior que o limite superior da normalidade). A
TC revelou um n&#xF3;dulo pulmonar com sinal do halo no lobo inferior esquerdo (<xref ref-type="fig" rid="f02">Figura 1</xref>) e nos linfonodos para-hilares
esquerdos. O exame histol&#xF3;gico de uma amostra de bi&#xF3;psia pulmonar obtida durante
a broncoscopia mostrou altera&#xE7;&#xF5;es inflamat&#xF3;rias inespec&#xED;ficas. As culturas para
micobact&#xE9;rias e fungos foram negativas. O resultado da sorologia por
contraimunoeletroforese foi positivo para histoplasmose. </p>
        <p>
<fig id="f02" orientation="portrait" position="float"><label>Figura 1</label><caption><title> TC ao n&#xED;vel dos lobos inferiores mostrando um n&#xF3;dulo circundado
por atenua&#xE7;&#xE3;o em vidro fosco (sinal do halo) no lobo inferior
esquerdo.</title></caption><graphic xlink:href="1806-3713-jbpneu-39-04-0523-gf01"/></fig>
</p>
        <p>O tratamento foi iniciado com itraconazol (400 mg/dia). Ap&#xF3;s 30 dias, a TC
mostrou que o tamanho do n&#xF3;dulo havia diminu&#xED;do pela metade. O paciente
apresentou melhora progressiva dos sintomas cl&#xED;nicos e redu&#xE7;&#xE3;o da adenopatia
para-a&#xF3;rtica. O tratamento foi mantido durante um ano, durante o qual o paciente
permaneceu assintom&#xE1;tico, o n&#xF3;dulo desapareceu completamente, e a linfadenopatia
regrediu. No entanto, o resultado da contraimunoeletroforese permaneceu positivo
para histoplasmose. </p>
        <p>Relatamos o caso de um paciente imunocompetente que apresentou sinal do halo e
linfadenopatia causada por histoplasmose, com boa resposta cl&#xED;nica ap&#xF3;s um ano
de tratamento com itraconazol (400 mg/dia). O <italic>Histoplasma
capsulatum</italic> &#xE9; um importante pat&#xF3;geno f&#xFA;ngico humano end&#xEA;mico que
pode causar uma grande variedade de quadros cl&#xED;nicos, desde doen&#xE7;a pulmonar
focal leve at&#xE9; infec&#xE7;&#xF5;es sist&#xEA;micas mortais.(
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
) Em um estudo, bi&#xF3;psias pulmonares a c&#xE9;u aberto de 155 pacientes com
les&#xF5;es pulmonares n&#xE3;o diagnosticadas mostraram que etiologias infecciosas foram
respons&#xE1;veis por 19% das les&#xF5;es, e o diagn&#xF3;stico mais comum nesse grupo foi
histoplasmose (41%).(
<xref rid="B02" ref-type="bibr">
<sup>2</sup>
</xref>
)
</p>
        <p>O sinal do halo &#xE9; caracterizado por uma opacidade em vidro fosco ao redor de um
n&#xF3;dulo, massa, ou &#xE1;rea arredondada de consolida&#xE7;&#xE3;o.(
<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>
) Esse sinal &#xE9; frequentemente um indicador precoce de aspergilose
pulmonar invasiva em pacientes imunossuprimidos,(
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
) mas tamb&#xE9;m pode indicar outras doen&#xE7;as f&#xFA;ngicas invasivas. </p>
        <p>Nosso paciente necessitou de tratamento com altas doses de itraconazol durante um
ano. Os antif&#xFA;ngicos az&#xF3;licos, tais como itraconazol e voriconazol, e a
anfotericina B t&#xEA;m atividade significativa contra <italic>H</italic>.
<italic>capsulatum</italic>. No entanto, aproximadamente 10% dos pacientes
hospitalizados por causa de histoplasmose morrem,(
<xref rid="B05" ref-type="bibr">
<sup>5</sup>
</xref>
) n&#xE3;o obstante a aus&#xEA;ncia de resist&#xEA;ncia antif&#xFA;ngica entre isolados
recuperados.(
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
)
</p>
        <p>Em suma, o sinal do halo na TC pode indicar histoplasmose ativa, que pode exigir
tratamento em longo prazo, mesmo em pacientes imunocompetentes. </p>
      </sec>
    </body>
  </sub-article>
</article>
</pmc-articleset>
